Bone Densitometer Systems Market size is estimated to reach ~USD 400 Million by the end of 2035 by growing at a CAGR of ~4% over the forecast period, i.e., 2023 – 2035. In addition to this, in the year 2022, the market size of bone densitometer systems was ~USD 300 Million. The major factor for the expansion of the global bone densitometer systems is the rising cases of bone disorders and related diseases including muscular dystrophy, and Duchene muscular dystrophy among the global population. Furthermore, if these diseases are not treated with effectiveness, they worsen over time and can lead to degenerative disease and orthopedic limitation which generates the need for bone densitometer systems. Thus, the rising cases of bone disorders such as osteoporosis are expected to bring lucrative growth opportunities for market growth during the forecast period. The National Library of Medicine published a report in 2018 that calculated the prevalence of osteoporosis to be more than 200 million people across the world. It also has been calculated that the occurrence of osteoporosis in women around the world is more than 23% and in men around the world was found to be almost 11%.
Bone densitometer systems are efficient in determining and diagnosing osteoporosis, osteopenia, and diseases that ultimately lead to the degeneration of bones, such as osteomalacia, osteoarthritis, and osteoporotic fractures. The main function of the bone densitometer system is to measure the bone density of patients which is beneficial for identifying the underlying diseases. The growth of the bone densitometer system market is attributed to growing cases of osteoporosis among the population, the surge in the incidence of accidents and traumas, and the development of new bone densitometer products by the major key players operating in the market. Furthermore, the increase in the number of product approvals by regulatory bodies is anticipated to provide remunerative opportunities for the expansion of the global bone densitometer systems during the forecast period.
Base Year |
2022 |
Forecast Year |
2023-2035 |
CAGR |
~4% |
Base Year Market Size (2022) |
~ USD 300 Million |
Forecast Year Market Size (2035) |
~ USD 400 Million |
Regional Scope |
|
Growth Drivers
Challenges
The global bone densitometer systems market is segmented and analyzed for demand and supply by application into osteoporosis & osteopenia, cystic fibrosis, chronic kidney disease, body composition measurement, and rheumatic arthritis. Out of these segments, the osteoporosis & osteopenia segment is estimated to gain the largest market share of about ~32% in the year 2035. The main reason for segment growth is the rising cases of osteoporosis & osteopenia owing to the adoption of a sedentary lifestyle and high junk. Also, the burgeoning geriatric population who are more prone to osteoporosis & osteopenia is considered to positively contribute towards segment growth. As per the data provided by the World Health Organization (WHO), the share of the population of age 60 or above in the world increased from 1 billion to 1.4 billion in 2022 and is projected to double by 2050 reaching around 2.1 billion. In addition to other factors, the rising incidence of traumas, accidents, and injuries is also expected to increase the cases of osteoporosis & osteopenia which are further anticipated to increase the utilization rate of bone densitometer systems in the upcoming years.
The bone densitometer systems market is also segmented and analyzed for demand and supply by end-user in hospitals, clinics, and others. Amongst these three segments, the hospital’s segment is expected to garner a significant share of around ~46% in the year 2035. The growth of the segment can be attributed to the rapidly growing cases of bone-related diseases, and the burgeoning of the geriatric population with a disability who requires full-time assistance and generally admits into hospitals. Moreover, the increasing investment in hospitals by governments of different nations, along with the rising healthcare expenditure, and the availability of the dedicated orthopedic section in the hospital are predicted to fuel the segment growth over the ensuing years. It was noted that spending on health care in the United States increased 2.7 percent in 2021 to USD 4.3 trillion, or USD 12,914 per person. Total expenditure on healthcare accounted for more than 18 percent of the region's GDP.
Our in-depth analysis of the global bone densitometer systems market includes the following segments:
By Type |
|
By Technology |
|
By Scan |
|
By Application |
|
By End User |
|
The market share of bone densitometer systems in North America, amongst the market in all the other regions, is projected to be the largest with a share of about ~35% by the end of 2035. The primary reason for market growth in the region is the presence of the blooming healthcare industry and the rising cases of amputations owing to numerous reasons including bone fractures and various bone illnesses. It is estimated that in the United States, every year, nearly 170,000 amputation procedures take place and around 3.5 million people are estimated to with limb loss by the year 2050. In addition to the aforementioned factors, the availability of major key market players operating in the market in the region and the escalation in the investment by them to develop advanced orthopedic power tools such as bone densitometer systems to make the treatment easier and cost-efficient is predicted to propel the market growth during the forecast period.
The European bone densitometer systems market is estimated to be the second largest, registering a share of about ~24% by the end of 2035, on the back of increasing preference for minimally invasive medical procedures. In addition to the other factors, the presence of major key players and increasing advancement in the associated technology are also expected to drive the growth of the market in the region over the forecast period. An up-surged manufacturing process of novel tools and other assistive equipment can also be observed in the region which is anticipated to create a positive outlook for market growth during the assessment period.
Further, the bone densitometer systems market in the Europe region, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2035. The availability of patient-friendly healthcare policies and the rising government campaigns promoting healthcare awareness among the people in the region is anticipated to increase the utilization rate of bone densitometer systems over the upcoming years.
In the News
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Author Credits: Radhika Gupta, Shivam Bhutani
Ans: The increasing prevalence of osteoporosis and the growing bone disorders is estimated to boost market growth during the forecast period
Ans: The market size of bone densitometer systems is anticipated to attain a CAGR of ~4% over the forecast period, i.e., 2023 – 2035.
Ans: High cost of bone densitometer along with the requirement of higher initial investment and lack of professionals in the healthcare industry are estimated to be the growth hindering factors for the market expansion.
Ans: The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Ans: The major players in the market are AMPall, Eurotec Medical Systems s.r.l., Medonica Co., Ltd., Scanflex Healthcare AB, BeamMed Ltd., Swissray Global Healthcare Holding Ltd., Diagnostic Medical Systems Group, OSI Systems, Inc., Hologic, Inc., GE Healthcare, and other key players.
Ans: The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by type, technology, application, scan, end-user, and by region
Ans: The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities
Submit Your Request For Proposal (RFP)